Relapse of intracranial germinoma 23 years postirradiation in a patient given growth hormone replacement.
AffiliationDepartment of Clinical Oncology, Christie Hospital NHS Trust, Manchester, United Kingdom.
MetadataShow full item record
AbstractThere is no clear evidence that growth hormone replacement therapy for treatment-related growth hormone deficiency in patients with childhood intracranial malignancies has a role in tumour relapse or second malignancy. A 16-year-old girl with an intracranial germinoma was treated with local radiotherapy and subsequently received growth hormone replacement therapy as an adult. Three years after starting growth hormone therapy, 23 years after her radiotherapy treatment, the patient's tumour recurred. Surveillance requirements for patients receiving growth hormone in this setting are discussed.
CitationRelapse of intracranial germinoma 23 years postirradiation in a patient given growth hormone replacement. 1997, 29 (1):41-4 Med. Pediatr. Oncol.
JournalMedical and Pediatric Oncology
- Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
- Authors: Chung TT, Drake WM, Evanson J, Walker D, Plowman PN, Chew SL, Grossman AB, Besser GM, Monson JP
- Issue date: 2005 Sep
- Treatment of intracranial germinoma.
- Authors: Xu W, Zhang B, Chen T, Sun W
- Issue date: 1995 May
- Recurrence of primary intracranial germinomas after complete response with radiotherapy: recurrence patterns and therapy.
- Authors: Ono N, Isobe I, Uki J, Kurihara H, Shimizu T, Kohno K
- Issue date: 1994 Oct
- Growth hormone and tumour recurrence.
- Authors: Ogilvy-Stuart AL, Ryder WD, Gattamaneni HR, Clayton PE, Shalet SM
- Issue date: 1992 Jun 20
- Growth hormone therapy and tumor recurrence. Findings in children with brain neoplasms and hypopituitarism.
- Authors: Arslanian SA, Becker DJ, Lee PA, Drash AL, Foley TP Jr
- Issue date: 1985 Apr